Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sunshine Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SBFM
Nasdaq
2834
https://www.sunshinebiopharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sunshine Biopharma Inc
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
- Apr 19th, 2024 12:00 pm
Sunshine Biopharma Announces Reverse Stock Split
- Apr 12th, 2024 1:00 pm
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
- Apr 1st, 2024 12:00 pm
Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 31st, 2024 12:49 pm
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
- Feb 15th, 2024 2:15 pm
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
- Feb 13th, 2024 2:00 pm
11 Hyper-Growth Stocks Billionaires Are Loading Up On
- Jan 25th, 2024 9:40 am
Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)
- Jan 23rd, 2024 12:03 pm
Sunshine Biopharma Moves Principal Office to New York City
- Dec 4th, 2023 1:30 pm
Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition
- Nov 13th, 2023 1:30 pm
Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance
- Sep 22nd, 2023 1:05 am
It's Down 26% But Sunshine Biopharma, Inc. (NASDAQ:SBFM) Could Be Riskier Than It Looks
- Sep 12th, 2023 10:09 am
When Will Sunshine Biopharma, Inc. (NASDAQ:SBFM) Breakeven?
- Aug 16th, 2023 11:10 am
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
- Aug 11th, 2023 12:30 pm
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)
- May 16th, 2023 6:15 pm
Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market
- May 16th, 2023 1:58 pm
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
- May 12th, 2023 12:00 pm
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
- May 11th, 2023 1:00 pm
Scroll